Dynamic life sciences leader with exceptional strengths in innovative product development, technical operations, commercialization strategy, clinical trials, and intellectual property. Demonstrated capabilities in building high-performing organizations and financing early-stage innovation. Wide-ranging technical expertise. Strong track record of building commercial enterprises based on cutting-edge science, setting ambitious milestones and achieving them ahead of schedule. Companies founded or co-founded include: - Applaud (now Avvio): raised $15 million, built out product pipeline encompassing urology and cardiovascular disease indications around novel lipid microsphere technology in-licensed from Caltech, advanced first therapeutic through highly accelerated preclinical work and into clinic; company now worth $100 MM based on 2022 round- specialty CRO Wave 80 Biosciences: founded out of graduate school, leveraged innovative flow-based assay methods and other assay development insights to bootstrap company to $5 MM annual revenues in highly competitive fieldEnergetic, high-value board member/advisor at select innovative, rapid-growth companies. Ph.D. in mechanical engineering, Stanford University, B.A. in political science and B.S. in mechanical engineering, Northwestern. At Stanford, was a Semiconductor Research Corporation Graduate Fellow, a Department of Mechanical Engineering Graduate Fellowship Engineering Merit Award recipient, and a MacArthur Affiliate at Stanford’s Center for International Security and Cooperation.